Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Will The Self-Administered Parenteral Market Valuation Change Between Now And 2029?

The market size for self-administered parenteral treatments has seen significant growth in the past few years. The expected growth from $24.57 billion in 2024 to $25.84 billion in 2025, with a compound annual growth rate (CAGR) of 5.2%, reflects this trend. This growth during the historic period is due to various factors such as an increase in chronic diseases, an aging population, initiatives from the government, programs for patient education and support, and higher occurrences of bone disorders.

The market size for self-administered parenteral medicine is anticipated to experience consistent expansion in the upcoming years. The market is projected to reach a value of $30.83 billion by 2029, growing at a compound annual growth rate (CAGR) of 4.5%. This growth over the forecast period can be ascribed to the rise in patient inclination towards home healthcare, utilization of telemedicine and remote patient supervision, initiatives towards patient education and support, as well as the expansion of personalized medicine. The forecast period also sees key trends like the incorporation of digital health solutions, personalized drug delivery systems, the rise of targeted therapies, and progress in biologics.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13927&type=smp

What Growth-Enabling Forces Are Impacting The Self-Administered Parenteral Market?

The surge in chronic diseases is anticipated to drive the expansion of the self-administered parenteral market. Chronic diseases are medical conditions that typically evolve gradually and frequently need continuous control and therapy. Self-administered parenteral items, which aid in independent treatment management for chronic diseases, can greatly increase adherence compared to oral medication. As an example, the National Institutes of Health, a government agency based in the U.S., projected that by 2050, the number of individuals aged 50 and over with at least one chronic disease will rise by 99.5%, from 71.522 million in 2020 to 142.66 million. Consequently, the increased prevalence of chronic diseases is propelling the growth of the self-administered parenteral market.

What Are The Main Segment Classifications In The Self-Administered Parenteral Market?

The self-administered parenteralmarket covered in this report is segmented –

1) By Product: Pre-Filled Syringes; Autoinjectors; Pen Injectors; Other Products

2) By Usage: Disposable; Reusable

3) By Distribution Channel: Hospital Pharmacies; Online Pharmacies; Home Healthcare Providers; Specialty Clinics; Other Distribution Channels

4) By Application: Cardiovascular Diseases; Diabetes; Osteoporosis; Pain Management; Hormone Replacement; Other Applications

Subsegments:

1) By Pre-Filled Syringes: Glass Pre-Filled Syringes; Plastic Pre-Filled Syringes

2) By Autoinjectors: Disposable Autoinjectors; Reusable Autoinjectors

3) By Pen Injectors: Insulin Pen Injectors; Growth Hormone Pen Injectors; Other Pen Injectors

4) By Other Products: Infusion Pumps; Needle-Free Injectors; Combination Devices

Which Emerging Trends Are Reshaping The Self-Administered Parenteral Market Landscape?

Top tier firms in the self-administered parenteral market are concentrating their efforts on creating novel products like the UDENYCA autoinjector, with the goal of expanding patient options and increasing treatment accessibility. An autoinjector is a clinically engineered device that delivers a specific drug dosage. The operation of these devices is straightforward and ensures an instant and dependable drug release upon skin contact. For instance, in May 2023, a biotech firm based in the US, Coherus BioSciences Inc., introduced the UDENYCA autoinjector, a type of self-injected parenteral medication in the United States market. The UDENYCA Autoinjector comes as a prefilled, single-use autoinjector that provides the patients with an extra method for pegfilgrastim administration. It was crafted to be easy-to-use with its push-on-skin mechanism facilitating immediate and dependable release of a full pegfilgrastim dose. Additionally, it has multiple user-friendly attributes such as quick dosing, simple construction, dual coverage, adaptable usage at home or clinic, and minimized risk of febrile neutropenia.

Which Firms Are Driving Innovation Within The Self-Administered Parenteral Market?

Major companies operating in the self-administered parenteral market report are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Sanofi S.A., AstraZeneca PLC, Roche Holding AG, Eli Lilly and Company, Novo Nordisk A/S, Becton, Dickinson and Company, Teva Pharmaceutical Industries Ltd., Mylan N.V., Terumo Corporation, Catalent Inc., Dexcom Inc., West Pharmaceutical Services Inc., Gerresheimer AG, Biocon Limited, Insulet Corporation, Halozyme Therapeutics Inc., Ypsomed AG, Antares Pharma Inc., SHL Medical AG, Owen Mumford Ltd., Novartis AG, Kaleo Inc., Haselmeier AG, Bespak (A Consort Medical Company), Senseonics Holdings Inc., ScPharmaceuticals Inc., Fresenius Kabi AG

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/self-administered-parenteral-global-market-report

What Are The Emerging Regional Trends Driving The Self-Administered Parenteral Market?

North America was the largest region in the self-administered parenteral market in 2024. The regions covered in the self-administered parenteral market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=13927&type=smp

Browse Through More Reports Similar to the Global Self-Administered Parenteral Market 2025, By The Business Research Company

Payer Services Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/payer-services-global-market-report

Personal Computers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/personal-computers-global-market-report

Physician And Other Health Practitioner Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/physician-and-other-health-practitioner-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model